Kiran Dole Selected Research

Antibodies

1/2016

A First-in-Human Study To Assess the Safety and Pharmacokinetics of Monoclonal Antibodies against Human Cytomegalovirus in Healthy Volunteers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kiran Dole Research Topics

Disease

2	Type 2 Diabetes Mellitus (MODY) 01/2008 - 12/2007
1	Non-alcoholic Fatty Liver Disease 01/2021
1	Hepatitis C 10/2017
1	Infections 10/2017
1	Hypersensitivity (Allergy) 01/2016
1	Hypertension (High Blood Pressure) 01/2008
1	Dyslipidemias (Dyslipidemia) 12/2007

Drug/Important Bio-Agent (IBA)

2	VildagliptinIBA 01/2008 - 12/2007
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 01/2021
1	pradigastatIBA 10/2017
1	Antiviral Agents (Antivirals)IBA 10/2017
1	DiglyceridesIBA 10/2017
1	TransferasesIBA 10/2017
1	AntibodiesIBA 01/2016
1	Angiotensin Receptor AntagonistsIBA 01/2008
1	Valsartan Drug Combination Amlodipine FDA Link 01/2008
1	Valsartan (Vals)FDA Link 01/2008
1	Ramipril (Altace)FDA LinkGeneric 01/2008
1	Amlodipine (Norvasc)FDA LinkGeneric 01/2008
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2008
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2008
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2008
1	Antihypertensive Agents (Antihypertensives)IBA 01/2008
1	IncretinsIBA 12/2007
1	Hormones (Hormone)IBA 12/2007
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2007

Therapy/Procedure

1	Glycemic Control 12/2007